Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical reported $58.98M in Trade Creditors for its fiscal quarter ending in March of 2023.

Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 17.42M 4.68M
Agios Pharmaceuticals AGIO:US USD 8.66M 9.95M
Alnylam Pharmaceuticals ALNY:US USD 62.24M 35.86M
Bluebird Bio BLUE:US USD 19.24M 5.86M
Esperion Therapeutics ESPR:US USD 17.06M 5.98M
Immunic Inc. VTL:US USD 5.24M 960K
Insmed INSM:US USD 59.28M 6.67M
Ionis Pharmaceuticals IONS:US USD 10.5M 7.42M
Kyowa Hakko Kirin 4151:JP JPY 66.29B 56.8B
MacroGenics MGNX:US USD 3.76M 1.14M
Mirati Therapeutics MRTX:US USD 22.32M 16.54M
Moderna Inc MRNA:US USD 389M 98M
PTC Therapeutics PTCT:US USD 26.31M 957K
Puma Biotechnology PBYI:US USD 8.59M 2.15M
Regeneron Pharmaceuticals REGN:US USD 599.5M 10.3M
Sarepta Therapeutics SRPT:US USD 106.71M 10.84M
Ultragenyx Pharmaceutical RARE:US USD 58.98M 15.71M
Vertex Pharmaceuticals VRTX:US USD 323.2M 19.3M